Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Sponsor: Northwell Health
A NA clinical study on Migraine With Aura and Migraine Without Aura, this trial is completed. The trial is conducted by Northwell Health and has accumulated 14 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2021 — Dec 2021 [monthly]
Completed NA
▶ Show 9 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Mar 2019 — Feb 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2018 — Mar 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Jan 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Northwell Health
- Rambam Health Care Campus
- Theranica
For direct contact, visit the study record on ClinicalTrials.gov .